Review of Issues and Solutions to Data Analysis Reproducibility and Data Quality in Clinical Proteomics.

Cloud technology Computational mass spectrometry Large scale data analysis Quality control approaches Reproducible analysis pipelines

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 26 9 2019
pubmed: 26 9 2019
medline: 21 10 2020
Statut: ppublish

Résumé

In any analytical discipline, data analysis reproducibility is closely interlinked with data quality. In this book chapter focused on mass spectrometry-based proteomics approaches, we introduce how both data analysis reproducibility and data quality can influence each other and how data quality and data analysis designs can be used to increase robustness and improve reproducibility. We first introduce methods and concepts to design and maintain robust data analysis pipelines such that reproducibility can be increased in parallel. The technical aspects related to data analysis reproducibility are challenging, and current ways to increase the overall robustness are multifaceted. Software containerization and cloud infrastructures play an important part.We will also show how quality control (QC) and quality assessment (QA) approaches can be used to spot analytical issues, reduce the experimental variability, and increase confidence in the analytical results of (clinical) proteomics studies, since experimental variability plays a substantial role in analysis reproducibility. Therefore, we give an overview on existing solutions for QC/QA, including different quality metrics, and methods for longitudinal monitoring. The efficient use of both types of approaches undoubtedly provides a way to improve the experimental reliability, reproducibility, and level of consistency in proteomics analytical measurements.

Identifiants

pubmed: 31552637
doi: 10.1007/978-1-4939-9744-2_15
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-371

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P024599/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208391/Z/17/Z
Pays : United Kingdom

Auteurs

Mathias Walzer (M)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.

Juan Antonio Vizcaíno (JA)

European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK. juan@ebi.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH